Clinical Trial Update: Late-Onset Treatment Study Extension Protocol [Phase 4]

View source ↗

Summary

Phase 4 study extension for late-onset Pompe disease and glycogen storage disease type II; the trial is completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type Ii
• Pompe Disease

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Pompe Disease (Late-Onset), Glycogen Storage Disease Type II (GSD-II) | Phase 4 | Status: COMPLETED | Results posted: 2012-01-05